biote Corp.
NASDAQ:BTMDMedical - Care Facilities
+$0.01 today
- Market cap
- $54.25M
- Beta
- 1.66
- P/E (TTM)
- 4.5
- EPS (TTM)
- $0.51
Volume 0.11M
Average 0.25M
BTMD Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
biote Corp.NASDAQ: BTMD
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities falls 82.6% from a year ago
Other current liabilities stood at $5.05M at the end of Q1 FY2026, down 82.6% from a year earlier and down 82.2% from the prior quarter. Over 3 fiscal years it compounded at +74.7% a year.
Context
- Other current liabilities amounted to 5.7% of total assets at the end of Q1 FY2026, down 17.8 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -82.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 22.5M USD
- Year-over-year change
- -25.8%
- 4-year CAGR
- +78.6%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.5M | -25.8% |
| FY2024 | 2024-12-31 | 30.32M | +399.7% |
| FY2023 | 2023-12-31 | 6.07M | +43.8% |
| FY2022 | 2022-12-31 | 4.22M | +90.7% |
| FY2021 | 2021-12-31 | 2.21M | — |
Other Current Liabilities vs competitors
How BTMD compares with its peers on the latest reported figures
- BTMD's Mar 2026 other current liabilities of $5.05M is the 4th highest of the 11 companies compared; the peer median is $3.22M.
- Its year-over-year change of -82.6% is the 9th highest of 10, against a peer median of +36.3%.
- Other current liabilities amounts to 5.7% of total assets for BTMD, versus a peer median of 5.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $308.06M | +70394.3% | +945.6% | 104.9% | |
| Mar 2026 | $27.02M | +70.3% | +34.0% | 54.3% | |
| Mar 2026 | $24.35M | -29.3% | +152.9% | 42.0% | |
| Mar 2026 | $5.05M | -82.6% | +74.7% | 5.7% | |
| Mar 2026 | $4.3M | +63.4% | -49.2% | 3.7% | |
ACTUActuate Therapeutics Inc | Mar 2026 | $3.52M | +184.4% | +20.0% | 39.5% |
| Mar 2026 | $2.92M | +36.3% | +45.8% | 0.6% | |
| Mar 2026 | $2.76M | -60.6% | -0.6% | 1.5% | |
| Mar 2026 | $2.2M | — | -28.3% | 6.5% | |
| Mar 2026 | $1.61M | +24.3% | +218.8% | 1.2% | |
| Mar 2026 | $0 | -100.0% | -7.4% | 0.0% | |
| Peer median (excluding BTMD) | $3.22M | +36.3% | +27.0% | 5.1% | |
Competitors are the stored peer set for BTMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 26.77M | 79.23M | 89M | 39.34M | 24.12M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.23M | 6.95M | 8.17M | 7.7M | 7.68M |
| Inventory | 9.62M | 11.18M | 17.31M | 14.85M | 19.06M |
| Other Current Assets | 3.94M | 0 | 308K | 111K | 10K |
| Total Current Assets | 47.09M | 101.18M | 122.34M | 68.13M | 54.67M |
| Property, Plant & Equipment (Net) | 2.69M | 3.56M | 3.1M | 10.22M | 13.45M |
| Goodwill | 0 | 0 | 0 | 5.83M | 5.83M |
| Intangible Assets | 4.55M | 5.07M | 4.97M | 9.38M | 4.27M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 1.84M | 24.88M | 28.74M | 24.79M |
| Other Non-current Assets | 0 | 0 | 0 | 72K | 4.6M |
| Total Non-current Assets | 7.25M | 10.47M | 32.95M | 54.24M | 52.94M |
| Total Assets | 54.33M | 111.65M | 155.3M | 122.37M | 107.61M |
| Account Payables | 4.35M | 4.11M | 4.16M | 5.81M | 6.83M |
| Short-term Debt | 5M | 6.25M | 6.25M | 6.25M | 6.25M |
| Tax Payables | 0 | 1.05M | 17K | 0 | 0 |
| Deferred Revenue | 1.71M | 1.97M | 3M | 2.96M | 3.02M |
| Other Current Liabilities | 2.21M | 4.22M | 6.07M | 30.32M | 22.5M |
| Total Current Liabilities | 17.31M | 18.77M | 22.22M | 51.51M | 44.99M |
| Long-term Debt | 31.96M | 112.09M | 106.63M | 101.2M | 100.78M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 802K | 926K | 1.32M | 1.55M | 1.1M |
| Other Non-current Liabilities | 802K | 36.21M | 59.99M | 67.41M | 8.84M |
| Total Non-current Liabilities | 32.89M | 151.15M | 169.63M | 173.06M | 113.02M |
| Total Liabilities | 50.21M | 169.92M | 191.84M | 224.57M | 158.01M |
| Common Stock | 0 | 6K | 6K | 4K | 4K |
| Retained Earnings | 4.17M | (44.46M) | (29.39M) | (100.3M) | (49.55M) |
| Accumulated OCI | (40K) | (5K) | (12K) | (35K) | (29K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | (13.82M) | (7.15M) | 3.73M | 8.14M |
| Total Equity | 4.13M | (58.27M) | (36.55M) | (102.2M) | (50.4M) |
| Total Debt | 37.34M | 120.43M | 114.87M | 110.86M | 109.92M |
| Net Debt | 10.57M | 41.2M | 25.87M | 71.52M | 85.8M |
biote Corp.
NASDAQ:BTMD
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.